Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma

Clinical trial NCT01650090 · COMPLETED

Trial details

NCT number: NCT01650090
Sponsor: Eleison Pharmaceuticals LLC.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Relapse of Osteosarcoma

Start date: 2012-08-01
Primary completion: 2018-11-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.